Acuerdos de Riesgo Compartido: Lecciones Para su Diseño e Implementación a la Luz de la Experiencia Internacional
ConclusionsThe participation of all actors and the clarification of critical elements and tasks are fundamental for the optimal development of the experiences. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - March 13, 2019 Category: International Medicine & Public Health Source Type: research
Back to the Future: In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments
ConclusionsWe conclude that because of the socioeconomic inequality mostly seen in lower and middle-income countries, it is difficult to define a cost-effectiveness threshold by region or a willingness-to-pay threshold affordable to the entire population. We consider that benchmark interventions might help to find an affordable willingness-to-pay threshold, and league table interventions might help policy makers, physicians, and the society to share the decision making. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - March 11, 2019 Category: International Medicine & Public Health Source Type: research
Cost Effectiveness of a Technology-Enhanced Diabetes Care Management Program in Mexico
ConclusionsBoth the PD and PD-TE were highly cost-effective from a Mexican health system perspective. Considering the economic impact of the diabetes epidemic and the widespread use of cellular technology in Mexico, implementation of PD-TE is warranted. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - March 11, 2019 Category: International Medicine & Public Health Source Type: research
Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish Children
ConclusionsAny difference in price between PHiD-CV and PCV13 is expected to be the key driver of vaccine choice for preventing childhood pneumococcal disease in Turkey. At price parity, PHiD-CV use is likely to be a dominant strategy over the use of PCV13. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - February 17, 2019 Category: International Medicine & Public Health Source Type: research
Agnet y Judicialization en Salud en Argentina
Publication date: December 2019Source: Value in Health Regional Issues, Volume 20Author(s): Andrés Freiberg, Jorge Nicolás Lafferriere, Martín ZambranoAbstractArgentina considers its first National HTA Agency (AGNET) amidst expectations that it would stop “the scourge of judicialization”. We suspect this argument is counterintuitive: the creation of HTA Agencies, or Health Benefits Packages in the Region, whatever their breadth, have so far failed to contain judicialisation by themselves. We discuss that judicialization thrives not only because of the laws of the land, but also because the design and creation of the...
Source: Value in Health Regional Issues - January 30, 2019 Category: International Medicine & Public Health Source Type: research
Factors That Predict Overall Patient Satisfaction With Oncology Hospital Care in Bulgaria
ConclusionsResults stress the relevance of reducing uncertainty in illness in patients with cancer by implementing a satisfactory patient-physician relationship in the management of the disease. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 12, 2019 Category: International Medicine & Public Health Source Type: research
Prevalence of Symptoms and Symptom Clusters of Patients on Dialysis in Uruguay
ConclusionsOur study confirms the presence of high symptom burden in dialysis patients in Uruguay. Several symptom clusters were identified having significant impact on the patients’ well-being. The identification of symptom clusters can help to understand common underlying pathways. It is possible that the management of symptom clusters may reduce symptom burden in these patients. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 12, 2019 Category: International Medicine & Public Health Source Type: research
The Burden of Macular Diseases in Central and Eastern Europe—Implications for Healthcare Systems
ConclusionsThere is an urgent need for the creation of a wAMD/DME treatment program in CEE to ensure that patients have timely access to the most appropriate treatments. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 9, 2019 Category: International Medicine & Public Health Source Type: research
Evaluations of Morphine and Fentanyl for Mechanically Ventilated Patients With Respiratory Disorders in Intensive Care: A Systematic Review of Methodological Trends and Reporting Quality
ConclusionsOur review identified poor reporting quality and high heterogeneity of methods used, potentially limiting the degree to which studies could be interpreted, decisions could be influenced, and findings could be generalized. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 9, 2019 Category: International Medicine & Public Health Source Type: research
Health Economics and Outcomes Research (HEOR) Knowledge Needs Assessment for Latin America
ConclusionsThe knowledge gap assessment provided current knowledge gap perceptions among members of the International Society for Pharmacoeconomics and Outcomes Research in Latin America. The survey data collected support a need for developing educational programs for topics with the highest perceived knowledge gap. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 9, 2019 Category: International Medicine & Public Health Source Type: research
Economic Benefit of Sponsored Controlled Clinical Trials: The Avoidable Cost in Drugs for the Treatment of Rheumatoid Arthritis: Beneficio económico de los ensayos clínicos controlados patrocinados: El gasto evitable en medicamentos para el tratamiento de la artritis reumatoidea
ConclusionThis work describes for the first time in Argentina the significant economic benefit that may represent for RA patients' health insurances the participation in CCTs with bDMARDs. It shows that during the execution of the CCT, its extension periods, or post study access programs, while medication provision is guaranteed, the economic burden imposed by the treatment of the RA is relieved. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 9, 2019 Category: International Medicine & Public Health Source Type: research
New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017
Publication date: December 2019Source: Value in Health Regional Issues, Volume 20Author(s): Marcos Santos, Stephen Stefani, Joao Paulo Reis Neto, Manoel Carlos SantosAbstractThe congress of the International Society for Pharmacoeconomics and Outcomes Research is one of the main worldwide forums for the dissemination of research and knowledge on healthcare economics. Brazil is the largest country in Latin America, with a per-capita gross domestic product of $15 200 in 2017 and healthcare expenditure of the order of $1 318 per inhabitant. Brazilian specialists participated actively in the society’s latest congress, which t...
Source: Value in Health Regional Issues - January 9, 2019 Category: International Medicine & Public Health Source Type: research
A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population
ConclusionsThe present study identified very small quantitative differences between UK- and Brazilian-derived SF-6D scores. Tests of agreement, however, showed that the impact of using different sets of preference weights in the construction of quality-adjusted life-year might be considered irrelevant. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 9, 2019 Category: International Medicine & Public Health Source Type: research
Inflammatory Bowel Disease in Latin America: A Systematic Review
Publication date: December 2019Source: Value in Health Regional Issues, Volume 20Author(s): Daniela Simian, Rodrigo Quera (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 9, 2019 Category: International Medicine & Public Health Source Type: research
Response to Letter to the Editor
Publication date: December 2019Source: Value in Health Regional Issues, Volume 20Author(s): Maria Calderon (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - January 6, 2019 Category: International Medicine & Public Health Source Type: research
